← Leaderboards
Leslie P Plotnik
Johns Hopkins University
$0
Attributed
$0
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 3
By mechanism
M01$0 · 3
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Justin Richard Bailey$16,021,335
- Richard Bruce Roden$11,133,737
- Christopher D. Saudek$7,602,238
- Petros C Karakousis$19,415,784
- Richard B. Markham$15,441,953
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchHuman SubjectDisease /Disorder Prevention /ControlInsulin Dependent Diabetes MellitusInsulinFamily GeneticsHormone TherapyDrug Administration Rate /DurationDrug Screening /EvaluationEarly DiagnosisEndocrine Disorder ChemotherapyGonadotropin Releasing FactorInjection /InfusionLongitudinal Human StudyMetabolism Disorder DiagnosisOral AdministrationPancreatic IsletsPituitary DwarfismPostnatal Growth DisorderAntibody TiteringPrediabetic StateAutoantibodyChemoprevention
Grant awards (9)
DIABETES PREVENTION TRIAL--TYPE I DIABETES ORAL INSULIN$0
M01 · FY2002 · RR
NATIONAL DIABETES PREVENTION TRIAL$0
M01 · FY2002 · RR
MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF GRF$0
M01 · FY2002 · RR
MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF GRF$0
M01 · FY2001 · RR
NATIONAL DIABETES PREVENTION TRIAL$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES ORAL INSULIN$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES ORAL INSULIN$0
M01 · FY2000 · RR
MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF GRF$0
M01 · FY2000 · RR
NATIONAL DIABETES PREVENTION TRIAL$0
M01 · FY2000 · RR